Skip to Main Content
Try STAT+ TODAY
Trending:
Health
Coronavirus
Biotech
First Opinion
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Biotech
STAT+

This biotech is betting dietary changes can reshape cancer care. Even if it works, can Faeth make a profit?

  • Jonathan Wosen

By Jonathan Wosen July 19, 2022

Reprints
Faeth designs specialized diets for cancer patients, which can include saag with collard greens and ginger garlic butter. Courtesy Faeth Therapeutics

For all the advances oncology researchers have made in genomics and precision medicine, one of the most basic questions for cancer patients remains one of the least understood.

What should I eat?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Jonathan Wosen

Jonathan Wosen

West Coast Biotech & Life Sciences Reporter

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter.

Tags

Create a display name to comment

This name will appear with your comment

Inside the fall of star MIT scientist David Sabatini
Inside the fall of star MIT scientist David Sabatini
Pfizer is scolded by a U.K. trade group for…
Pfizer is scolded by a U.K. trade group for remarks its CEO made about vaccination
When women are denied an abortion, their children fare…
When women are denied an abortion, their children fare worse than peers
Inside the fall of star MIT scientist David Sabatini
Inside the fall of star MIT scientist David Sabatini
Federal panel approves plans to safeguard lab-made virus research
Federal panel approves plans to safeguard lab-made virus research
After bullying allegations, Eric Lander will return to run…
After bullying allegations, Eric Lander will return to run a lab at the Broad Institute

Recommended Stories